Showing results (161-170 of 166) with videos related to
Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 166 results.
ESC Heart Failure|October 16, 2021
'Time is prognosis' in heart failure: time-to-treatment initiation as a modifiable risk factorAmr Abdin, Stefan D Anker, Javed Butler, et al.Scientific Data|August 23, 2024
UK Reproducibility Network open and transparent research practices survey datasetLukas Hughes-Noehrer, Noémie Aubert Bonn, Marcello De Maria, et al.International Journal of Cardiology|March 17, 2018
Benefits and limitations of implementing Chronic Care Model (CCM) in primary care programs: A systematic reviewE K Yeoh, Martin C S Wong, Eliza L Y Wong, et al.Journal of Cachexia, Sarcopenia and Muscle|December 31, 2011
The ACT-ONE trial, a multicentre, randomised, double-blind, placebo-controlled, dose-finding study of the anabolic/catabolic transforming agent, MT-102 in subjects with cachexia related to stage III and IV non-small cell lung cancer and colorectal cancer: study designAndrew J Stewart Coats, Venkatesan Srinivasan, Jayaraman Surendran, et al.European Heart Journal|August 9, 2014
New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypesMichele Senni, Walter J Paulus, Antonello Gavazzi, et al.Journal of the American Medical Directors Association|June 7, 2011
Sarcopenia with limited mobility: an international consensusJohn E Morley, Angela Marie Abbatecola, Josep M Argiles, et al.Pageof 17